Skip to main content
SpringerLink
Log in

Are current therapies useful for the prevention of postherpetic neuralgia?

A critical analysis of the literature

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Study objective:To determine whether current therapies are useful in preventing postherpetic neuralgia (PHN) by analysis of study designs and pooled results.

Design:Meta-analysis of all controlled studies investigating PHN prevention in the immunocompetent host. Articles were identified through MEDLINE, Index Medicus and bibliographic reviews of major texts and review articles. Studies meeting eligibility criteria were independently assessed using explicit methodologic criteria for validity and generalizability in clinical trials. Pooled analysis was also performed where appropriate.

Measurements and main results:Twenty-one investigations met eligibility criteria and primarily addressed the use of antiviral agents and corticosteroids. Among studies with strong designs, no evidence of benefit was found for acyclovir or corticosteroids. Pooled results showed no significant effect of acyclovir on the prevention of PHN (odds ratio 0.81, 95% confidence interval 0.56, 1.11). The strongest studies that found potential efficacy in PHN prevention involved adenosine monophosphate and idoxuridine in dimethyl sulfoxide, but problems with clinical application limit the use of these compounds. Outcome definition, compliance assessment, power estimation, and method of randomization were infrequently addressed aspects of design.

Conclusion:Currently there is no proven useful therapy for the prevention of PHN. The benefits of acyclovir and corticosteroids are limited but key questions remain regarding these medications. A clear consensus definition of PHN is needed to improve future investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burgoon CF, Burgoon JS, Baldridge DG. The natural history of herpes zoster. JAMA. 1957;163:265–9.

    Google Scholar 

  2. deMorgas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol. 1957;75:193–6.

    Google Scholar 

  3. Ragozzino MW, Melton LF, Kurland LT. Population-based study of herpes zoster and its sequelae. Medicine. 1982;61:310–6.

    Article  PubMed  CAS  Google Scholar 

  4. Sauer GC. Herpes zoster. Arch Dermatol. 1955;71:488–91.

    CAS  Google Scholar 

  5. Bean B, Braun C, Balfour HH. Acyclovir therapy for acute herpes zoster. Lancet. 1982;2:118–21.

    Article  PubMed  CAS  Google Scholar 

  6. Sackett DL, Haynes RE, Tugwell P, eds. Clinical epidemiology: a basic science for clinicians. Boston, Little, Brown and Co., 1985;171–97.

    Google Scholar 

  7. DerSimonian R, Charette LJ, McPeek B, Mostellar F. Reporting on methods in clinical trials. N Engl J Med. 1982;306:1332–7.

    Article  PubMed  CAS  Google Scholar 

  8. Esmann V, Ipsen J, Peterslund NA, Seyer-Hansen K, Schonheyder H, Juhl H. Therapy of acute herpes zoster with acyclovir in the non-immunocompromised host. Am J Med. 1982;73:320–5.

    Article  PubMed  CAS  Google Scholar 

  9. McGill J, MacDonald DR, Fall C, McKendrick GDW, Coppelstone A. Intravenous acyclovir in acute herpes zoster infection. Infection. 1983;6:157–61.

    Article  CAS  Google Scholar 

  10. Juel-Jensen BE, Khan JA, Pasvol G. High dose intravenous acyclovir in the treatment of zoster: a double-blind, placebo controlled trial. J Infect. 1983;6(suppl. 1):31–6.

    Article  PubMed  CAS  Google Scholar 

  11. McKendrick MW, Care C, Burke C, Hickmott E, McKendrick GDW. Oral acyclovir in herpes zoster. J Antimicrob Chemother. 1984;15:661–5.

    Article  Google Scholar 

  12. Wood MJ, Ogan PH, McKendrick MW, Care DC, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988;85:79–83.

    PubMed  CAS  Google Scholar 

  13. Huff JC, Bean B, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med. 1988;85:84–9.

    Article  PubMed  CAS  Google Scholar 

  14. Juel-Jensen BE, MacCallum FO, MacKenzie AMR, Pike MC. Treatment of zoster with idoxuridine in dimethyl sulphoxide: results of two double-blind controlled trials. Br Med J. 1970;4:776–80.

    PubMed  CAS  Google Scholar 

  15. Widenhoff KE, Ipsen J, Esmann V, Ingemann-Jensen J, Poulsen JH. Treatment of herpes zoster with idoxuridine ointment, including a multivariate analysis of symptoms and signs. Scand J Infect Dis. 1979;11:1–9.

    Google Scholar 

  16. Wildenhoff KE, Esmann V, Ipsen J. Treatment of trigeminal and thoracic zoster with idoxuridine. Scand J Infect Dis. 1981;13:257–62.

    PubMed  CAS  Google Scholar 

  17. Sklar SH, Blue WT, Alexander EF, Bodian CA. Herpes zoster: the treatment and prevention of neuralgia with adenosine monophosphate. JAMA. 1985;253:1427–30.

    Article  PubMed  CAS  Google Scholar 

  18. Galbraith AW. Treatment of acute herpes zoster with amantidine hydrochloride. Br Med J. 1973;4:693–5.

    Article  PubMed  CAS  Google Scholar 

  19. Galbraith AW. Prevention of post-herpetic neuralgia by amantadine hydrochloride. Br J Clin Pract. 1983;Sept:304–6.

    Google Scholar 

  20. Elliott FA. Treatment of herpes zoster with high doses of prednisone. Lancet. 1964;2:610–1.

    Article  PubMed  CAS  Google Scholar 

  21. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA. 1970;211:1681–3.

    Article  PubMed  CAS  Google Scholar 

  22. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol. 1980;102:551–5.

    Article  PubMed  CAS  Google Scholar 

  23. Clemmensen OJ, Andersen KE. ACTH versus placebo in herpes zoster treatment. Clin Exp Dermatol. 1984;9:557–63.

    Article  PubMed  CAS  Google Scholar 

  24. Esmann V, Kroon S, Peterslund NA. Prednisolone does not prevent post-herpetic neuralgia. Lancet. 1987;2:126–9.

    Article  PubMed  CAS  Google Scholar 

  25. Kernbaum S, Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA. 1981;246:132–4.

    Article  PubMed  CAS  Google Scholar 

  26. Levy DW, Banerjee AK, Glenny HP. Cimetidine in the treatment of herpes zoster. J R Coll Phys (London). 1985;19:96–8.

    CAS  Google Scholar 

  27. Perez-Hernandez E. Dehydroemetine therapy for herpes zoster. Cutis. 1980;25:424–6.

    Google Scholar 

  28. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1981;29–30.

    Google Scholar 

  29. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley and Sons, 1981;165–8.

    Google Scholar 

  30. Feinstein AR. Clinical epidemiology. Philadelphia: W.B. Saunders, 1985;177–9.

    Google Scholar 

  31. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728–33.

    Article  PubMed  CAS  Google Scholar 

  32. L’Abbe KA, Defsky AS, O’Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107:224–33.

    PubMed  CAS  Google Scholar 

  33. Sacks HS, Berrier J, Reitman D. Meta-analyses of randomized controlled trials. N Engl J Med. 1987;316:450–64.

    Article  PubMed  CAS  Google Scholar 

  34. Friedman LM, Furberg CD, Demets DL. Fundamentals of clinical trials. Boston: John Wright/PSG Inc., 1985.

    Google Scholar 

  35. Cobo LM, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986;93:763–70.

    PubMed  CAS  Google Scholar 

  36. Sherlock CH, Corey L. Adenosine monophosphate for the treatment of varicella zoster infections: a large dose of caution. JAMA 1985;253:1444–5.

    Article  PubMed  CAS  Google Scholar 

  37. Sawyer MH. Treatment and prevention of varicella-zoster virus infections. In: Straus SE, moderator. Varicella-zoster virus infections: biology, natural history, treatment and prevention. Ann Intern Med. 1988;108:221–37.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for the Study of Aging and Human Development, Duke University Medical Center, Box 3003, 27710, Durham, NC

    Kenneth E. Schmader MD & Stephanie Studenski MD, MPH

Authors
  1. Kenneth E. Schmader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Studenski MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from the Geriatric Research, Education and Clinical Center (GRECC) and Rehabilitation Medicine Service, Durham Veterans Administration Medical Center; and the Division of Geriatrics, Department of Medicine, and the Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina.

Supported by the Veterans Administration Geriatric Fellowship Program.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmader, K.E., Studenski, S. Are current therapies useful for the prevention of postherpetic neuralgia?. J Gen Intern Med 4, 83–89 (1989). https://doi.org/10.1007/BF02602345

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02602345

Key words

Search

Navigation